Your session is about to expire
← Back to Search
EnACT Training for Dementia Caregivers (EnACT Trial)
N/A
Waitlist Available
Led By Jacqueline Eaton
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at six timepoints over 14 weeks.
Awards & highlights
EnACT Trial Summary
This trial is designed to develop and test an intervention called EnACT that would enhance active caregiver skill training to prepare caregivers to better manage behavioral symptoms in order to improve ADRD caregiver wellbeing.
Who is the study for?
This trial is for primary, informal caregivers aged 18 or older who support family members with Alzheimer's disease or related dementia (ADRD). Participants must be able to read and speak English. It excludes professional caregivers and individuals under 18 or those with poor English fluency.Check my eligibility
What is being tested?
The trial is testing the Enhancing Active Caregiver Training (EnACT) intervention designed to help caregivers manage behavioral symptoms of ADRD. The study involves developing EnACT through group meetings with caregivers, then assessing its usefulness and impact on caregiver stress and well-being.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on skill training, traditional physical side effects are not applicable. However, participants may experience emotional discomfort when discussing caregiving challenges.
EnACT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at one timepoint pre-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at one timepoint pre-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline Capacity to Adapt at 14 weeks
Change from Baseline Caregiver Capacity to Appraise Demands at 14 weeks
Change from Baseline Imagined Interactions at 14 weeks
Secondary outcome measures
Caregiver Well-being
Perceived Stress
Other outcome measures
Control
EnACT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Aims 2 & 3: InterventionExperimental Treatment1 Intervention
A Stage 1b pilot study will be conducted to test the feasibility and acceptability (Aim 2) of the EnACT intervention and potential mechanisms of change over time and their subsequent impact on proximal and distal outcomes (Aim 3). This arm will use a randomized waitlist control design.
Group II: Aim 1: Focus GroupsActive Control1 Intervention
A series of three sequential focus groups will be used to gather ADRD caregiver feedback about EnACT intervention techniques, including frequency, duration, delivery, feasibility, acceptability, and relevance of the intervention. Between focus groups, we will refine and edit the EnACT intervention in an iterative process. Intervention scenarios and activities will be chosen and refined as part of Aim 1 in preparation for testing feasibility and acceptability.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhancing Active Caregiver Training
2023
N/A
~40
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,682 Total Patients Enrolled
8 Trials studying Dementia
668 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,023 Total Patients Enrolled
266 Trials studying Dementia
23,625,320 Patients Enrolled for Dementia
Jacqueline EatonPrincipal InvestigatorUniversity of Utah
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are the main person responsible for taking care of a family member with Alzheimer's disease or related dementia.You are 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Aims 2 & 3: Intervention
- Group 2: Aim 1: Focus Groups
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many volunteers are involved in this research endeavor?
"Affirmative. Clinicaltrials.gov features information on the trial, which was initially published on February 23rd 2022 and has since been revised. It is actively searching for 40 volunteers across a single medical centre."
Answered by AI
Is this research program currently accepting participants?
"Affirmative. The clinicaltrials.gov website suggests that this scientific experiment, which was originally advertised on February 23rd 2022, is currently recruiting participants. Around 40 persons are required to take part at a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger